Seminars in Hematology
Volume 43, Supplement 3 , Pages S10-S12, April 2006

The Precautionary Principle and Emerging Biologic Risks: Lessons From Human Immunodeficiency Virus in Blood Products

  • Michael A. Stoto

      Affiliations

    • Corresponding Author InformationAddress correspondence to Michael A. Stoto, PhD, RAND Health, 1200 S Hayes St, Arlington, VA 22202.

RAND Health, Arlington, VA.

In times of crisis, such as during the early 1980s when acquired immune deficiency syndrome (AIDS) was first recognized as a threat to the blood supply, it can be difficult to find reliable evidence upon which to base appropriate public health policies. Unreliable evidence produces substantial scientific uncertainty. Yet despite ambiguity and unanswered questions, decisions must be made and policy established to protect people’s health. The precautionary principle provides important guidelines for public health policy decision making that are of particular value in times of crisis, such as the emergence of a new pathogen: be open and honest about scientific uncertainty; communicate with the public; and consider immediate, adaptable policy decisions. Ongoing research into the important uncertainties and review of policies in light of the data that emerge are crucial to the development of good public policy.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Summary of Stoto MA: The precautionary principle and emerging biological risks: lessons from swine flu and HIV in blood products. Public Health Rep 117:546-52, 2002. Adapted with permission from Michael A. Stoto and Public Health Reports (2002;117:546-52). Copyright 2002, Association of Schools of Public Health.

PII: S0037-1963(06)00027-8

doi:10.1053/j.seminhematol.2006.02.003

Seminars in Hematology
Volume 43, Supplement 3 , Pages S10-S12, April 2006